In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study
Open Access
- 20 September 2019
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 197 (6) , 699-707
Abstract
Purpose: In patients with idiopathic pulmonary fibrosis (IPF), hospitalizations are associated with high mortality. We sought to determine in-hospital mortality rates and factors associated with in-hospital mortality in patients with IPF. Methods: Patients with IPF were identified from the Premier Healthcare Database, a representative administrative dataset that includes > 20% of hospital discharges in the US, using an algorithm based on diagnostic codes and billing data. We used logistic regression to analyze associations between patient-, hospital-, and treatment-related characteristics and a composite primary outcome of death during the index visit, lung transplant during the index visit and > 1 day after admission, or death during a readmission within 90 days. Results: The cohort comprised 6665 patients with IPF hospitalized between October 2011 and October 2014. A total of 963 (14.4%) met the primary outcome. Factors significantly associated with a higher risk of the primary outcome included mechanical ventilation [odds ratio 4.65 (95% CI 3.73, 5.80)], admission to the intensive care unit [1.83 (1.52, 2.21)], treatment with opioids (3.06 [2.57, 3.65]), and a diagnosis of pneumonia [1.44 (1.21, 1.71)]. Factors significantly associated with a lower risk included concurrent chronic obstructive pulmonary disease [0.65 (0.55, 0.77)] and female sex [0.67 (0.57, 0.79)]. Conclusions: Patients with IPF, particularly those receiving mechanical ventilation or intensive care, are at substantial risk of death or lung transplant during hospitalization or death during a readmission within 90 days.Keywords
Funding Information
- This study was funded by Boehringer Ingelheim Pharmaceuticals, Inc as a collaboration with Duke Clinical Research Institute and Premier, Inc.
This publication has 35 references indexed in Scilit:
- Idiopathic Pulmonary Fibrosis in United States Automated Claims: Incidence, Prevalence, and Algorithm ValidationAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trialsThe Lancet Respiratory Medicine, 2015
- Outcomes After Hospitalization in Idiopathic Pulmonary FibrosisChest, 2015
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11The Lancet Respiratory Medicine, 2014
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2014
- Site of hospital readmission and mortality: a population-based retrospective cohort studyCMAJ Open, 2014
- Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary FibrosisChest, 2010
- Sex differences in physiological progression of idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2008
- Incidence and Prevalence of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006